Correlation Between Neuropace and Iradimed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Iradimed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Iradimed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Iradimed Co, you can compare the effects of market volatilities on Neuropace and Iradimed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Iradimed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Iradimed.

Diversification Opportunities for Neuropace and Iradimed

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Neuropace and Iradimed is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Iradimed Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iradimed and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Iradimed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iradimed has no effect on the direction of Neuropace i.e., Neuropace and Iradimed go up and down completely randomly.

Pair Corralation between Neuropace and Iradimed

Given the investment horizon of 90 days Neuropace is expected to generate 1.94 times less return on investment than Iradimed. In addition to that, Neuropace is 2.7 times more volatile than Iradimed Co. It trades about 0.01 of its total potential returns per unit of risk. Iradimed Co is currently generating about 0.06 per unit of volatility. If you would invest  4,608  in Iradimed Co on November 3, 2024 and sell it today you would earn a total of  1,313  from holding Iradimed Co or generate 28.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Iradimed Co

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Iradimed 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Iradimed Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile primary indicators, Iradimed exhibited solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and Iradimed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Iradimed

The main advantage of trading using opposite Neuropace and Iradimed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Iradimed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iradimed will offset losses from the drop in Iradimed's long position.
The idea behind Neuropace and Iradimed Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.